Fundz
New|Fundz now works inside Claude2 min

Everyone is chasing signals. Fundz is what comes next.

Everyone gets the same alerts the same morning. Fundz brings more than a dozen live business signals together on each company, ranks every company against your ICP, and each morning delivers the best few: who to reach out to, why, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

Valion Bio Secures Funding of $8.4 Million

PUBLIC · VBIOOct 07, 2026

Amount Raised

$8.4 Million

Round Type

Series B

BiotechnologyHealth Care

Investors

3i, Lp

Description

Valion Bio, Inc. has entered into a Securities Purchase Agreement with 3i, LP, resulting in an aggregate purchase price of up to $8.4 million. This funding involves the purchase of Series B Non-Voting Convertible Preferred Shares and associated warrants. The financial support will enable Valion Bio to further its research and development efforts

Company Information

Company

Valion Bio

About

Valion Bio, Inc. is a Delaware corporation focused on advancing treatments for allergy, asthma, and other chronic diseases. The company aims to innovate in the MedTech industry. Valion Bio is dedicated to improving patient outcomes through targeted solutions.

Fundz sees it the moment Valion Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael, Chief Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Valion Bio's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Valion Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.